Castration-resistant prostate cancer exhibits resistance to androgen deprivation therapy mainly because IL-23 secreted by MDSCs activates the androgen receptor (AR) and the STAT3/RORγ signaling axis in prostate tumor cells. Here, AR is linked to Familial prostate cancer.